Hear AtLast Holdings, Inc. (HRAL)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -109.93 Thousand USD | -5.39% |
| 2022 | -104.31 Thousand USD | 37.46% |
| 2021 | -166.79 Thousand USD | 48.88% |
| 2020 | -326.3 Thousand USD | 59.77% |
| 2019 | -811.1 Thousand USD | -26936.67% |
| 2018 | -3000.00 USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 100.0% |
| 2014 | -1.07 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -42.69 Thousand USD | -24.64% |
| 2023 Q4 | -34.25 Thousand USD | -49.5% |
| 2023 FY | -109.93 Thousand USD | -5.39% |
| 2023 Q3 | -22.91 Thousand USD | 29.62% |
| 2023 Q2 | -32.55 Thousand USD | -60.98% |
| 2023 Q1 | -20.22 Thousand USD | 8.8% |
| 2022 Q4 | -22.17 Thousand USD | -10.08% |
| 2022 Q3 | -20.14 Thousand USD | 66.48% |
| 2022 Q1 | -1910.00 USD | 97.27% |
| 2022 FY | -104.31 Thousand USD | 37.46% |
| 2022 Q2 | -60.09 Thousand USD | -3046.07% |
| 2021 Q3 | -19.75 Thousand USD | 12.84% |
| 2021 Q4 | -70.04 Thousand USD | -254.63% |
| 2021 Q2 | -22.66 Thousand USD | -97.04% |
| 2021 Q1 | -11.5 Thousand USD | -38.55% |
| 2021 FY | -166.79 Thousand USD | 48.88% |
| 2020 Q2 | -289.49 Thousand USD | -1788.39% |
| 2020 Q3 | -13.44 Thousand USD | 95.36% |
| 2020 Q4 | -8300.00 USD | 38.24% |
| 2020 Q1 | -15.33 Thousand USD | 97.24% |
| 2020 FY | -326.3 Thousand USD | 59.77% |
| 2019 Q4 | -556.15 Thousand USD | -736.32% |
| 2019 FY | -811.1 Thousand USD | -26936.67% |
| 2019 Q2 | -87.62 Thousand USD | 13.1% |
| 2019 Q1 | -100.83 Thousand USD | 51.2% |
| 2019 Q3 | -66.5 Thousand USD | 24.1% |
| 2018 FY | -3000.00 USD | 0.0% |
| 2018 Q4 | -206.62 Thousand USD | -27449.33% |
| 2018 Q2 | -1500.00 USD | 0.0% |
| 2018 Q3 | -750.00 USD | 50.0% |
| 2017 FY | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2015 FY | - USD | 100.0% |
| 2014 FY | -1.07 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | 109.442% |
| Ansell Limited | 129.3 Million USD | 100.085% |
| Ansell Limited | 129.3 Million USD | 100.085% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 31.13 Million USD | 100.353% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | 93.111% |
| Psykey, Inc. | -797.5 Thousand USD | 86.216% |
| ConvaTec Group Plc | 262.7 Million USD | 100.042% |
| ConvaTec Group Plc | 262.7 Million USD | 100.042% |
| Encision Inc. | -640.78 Thousand USD | 82.844% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 22.481% |
| Innovative MedTech Inc. | -4.27 Million USD | 97.428% |
| LifePoint, Inc. | -7.49 Million USD | 98.533% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 98.304% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | 133.312% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | 10.546% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | 76.474% |
| SmileDirectClub, Inc. | -241.15 Million USD | 99.954% |
| Sector 10, Inc. | -39.84 Thousand USD | -175.901% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | 100.034% |
| SheerVision, Inc. | 155.72 Thousand USD | 170.592% |
| United Health Products, Inc. | -2.42 Million USD | 95.47% |
| Vasamed, Inc. | 4.74 Million USD | 102.318% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 95.208% |
| Yubo International Biotech Limited | -1.2 Million USD | 90.879% |